scispace - formally typeset
S

Subash Babu

Researcher at National Institutes of Health

Publications -  212
Citations -  5811

Subash Babu is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Tuberculosis & Immune system. The author has an hindex of 35, co-authored 177 publications receiving 4584 citations. Previous affiliations of Subash Babu include Indian Council of Medical Research & Science Applications International Corporation.

Papers
More filters
Journal ArticleDOI

Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

TL;DR: It is demonstrated that interleukin-1 (IL-1) confers host resistance through the induction of eicosanoids that limit excessive type I interferon (IFN) production and foster bacterial containment and it is established that host-directed immunotherapy with clinically approved drugs that augment prostaglandin E2 levels in these settings prevented acute mortality of Mtb-infected mice.
Journal ArticleDOI

Regulatory networks induced by live parasites impair both Th1 and Th2 pathways in patent lymphatic filariasis: implications for parasite persistence.

TL;DR: It is concluded that a profound impairment of live parasite-specific Th1 and Th2 immune responses occurs in lymphatic filariasis that is governed at the transcriptional level by a complex interplay of inhibitory mediators.
Journal ArticleDOI

Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020

Manoj V Murhekar, +73 more
TL;DR: Seroprevalence of SARS-CoV-2 was low among the adult population in India around the beginning of May 2020, and males, living in urban slums and occupation with high risk of exposure to potentially infected persons were associated with seropositivity.
Journal ArticleDOI

Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery disease.

TL;DR: It appears that transition from T2DM or CAD to T2 DM-CAD co-morbidity is associated with strong down regulation of Th2 cytokines and enhancement of Th1 responses.